Gradient Investments LLC purchased a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,265 shares of the medical technology company’s stock, valued at approximately $315,000.
Other hedge funds have also recently made changes to their positions in the company. Atalanta Sosnoff Capital LLC purchased a new position in shares of Teleflex in the fourth quarter valued at $280,000. Legal & General Group Plc increased its position in shares of Teleflex by 5.8% in the third quarter. Legal & General Group Plc now owns 90,332 shares of the medical technology company’s stock valued at $21,854,000 after buying an additional 4,929 shares in the last quarter. Wealth Enhancement Advisory Services LLC purchased a new position in shares of Teleflex in the third quarter valued at $955,000. California Public Employees Retirement System increased its position in shares of Teleflex by 5.3% in the third quarter. California Public Employees Retirement System now owns 102,182 shares of the medical technology company’s stock valued at $24,725,000 after buying an additional 5,182 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Teleflex by 1.6% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 128,651 shares of the medical technology company’s stock valued at $31,130,000 after buying an additional 2,050 shares in the last quarter. Institutional investors and hedge funds own 89.22% of the company’s stock.
Shares of Teleflex Incorporated (NYSE TFX) opened at $254.95 on Wednesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 3.70 and a current ratio of 4.72. The company has a market capitalization of $11,496.57, a price-to-earnings ratio of 31.55, a P/E/G ratio of 1.88 and a beta of 1.15. Teleflex Incorporated has a 52 week low of $175.00 and a 52 week high of $288.78.
A number of research analysts have recently weighed in on the company. Leerink Swann restated a “buy” rating and issued a $321.00 price target (up previously from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Stephens restated a “buy” rating and issued a $300.00 price target on shares of Teleflex in a research report on Thursday, January 18th. ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Deutsche Bank cut Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target for the company. in a research report on Tuesday, November 14th. Finally, Piper Jaffray Companies assumed coverage on Teleflex in a research report on Friday, November 10th. They issued an “overweight” rating and a $295.00 price target for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $283.89.
In related news, Director George Babich, Jr. sold 2,500 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $263.38, for a total transaction of $658,450.00. Following the sale, the director now owns 10,583 shares of the company’s stock, valued at $2,787,350.54. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $276.44, for a total value of $55,288.00. Following the sale, the director now directly owns 8,080 shares in the company, valued at approximately $2,233,635.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,100 shares of company stock worth $2,671,994. Corporate insiders own 2.39% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Gradient Investments LLC Acquires New Stake in Teleflex Incorporated (TFX)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/14/gradient-investments-llc-acquires-new-stake-in-teleflex-incorporated-tfx.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.